Previous Close | 9.75 |
Open | 9.77 |
Bid | 8.08 x 1200 |
Ask | 10.60 x 1400 |
Day's Range | 9.74 - 10.07 |
52 Week Range | 9.24 - 21.86 |
Volume | |
Avg. Volume | 519,711 |
Market Cap | 553.034M |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | 30.31 |
EPS (TTM) | 0.32 |
Earnings Date | Jul 26, 2022 - Aug 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for VNDA
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at Digestive Disease Week (DDW) 2022, to be held in San Diego, CA and online from May 21-24, 2022.
Vanda (VNDA) delivered earnings and revenue surprises of -1,000% and 3.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2022.